Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor

European Journal of Neuroscience

Volumn 20, Issue 11, 2004, Pages 3121-3130

  Georgievska, Biljana ^a   Carlsson, Thomas ^a   Lacar, Benjamin ^a   Winkler, Christian ^a   Kirik, Deniz ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Dopamine; Glial cell line derived neurotrophic factor; Lentivirus; Transplantation; Tyrosine hydroxylase

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEIN; TYROSINE 3 MONOOXYGENASE; VESICULAR ACETYLCHOLINE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CELL SUSPENSION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; GENE OVEREXPRESSION; GRAFT SURVIVAL; HISTOLOGY; INNERVATION; MESENCEPHALON; MOTOR PERFORMANCE; NERVE FIBER GROWTH; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; RISK BENEFIT ANALYSIS;

ADRENERGIC AGENTS; AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CELL COUNT; CELL TRANSPLANTATION; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; EMBRYO; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GRAFT SURVIVAL; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MESENCEPHALON; NERVE GROWTH FACTORS; OXIDOPAMINE; PARKINSON DISEASE; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; ROTAROD PERFORMANCE TEST; STEREOTAXIC TECHNIQUES; STEREOTYPED BEHAVIOR; TIME FACTORS; TYROSINE 3-MONOOXYGENASE; UPPER EXTREMITY; VESICULAR BIOGENIC AMINE TRANSPORT PROTEINS; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 10844229392     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2004.03770.x     Document Type: Article

References (38)

1. Apostolides, C., Sanford, E., Hong, M. & Mendez, I. (1998) Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells. Neuroscience, 83, 363-372.
2. Brundin, P., Isacson, O. & Björklund, A. (1985) Monitoring of cell viability in suspensions of embryonic CNS tissue and its use as a criterion for intracerebral graft survival. Brain Res., 331, 251-259.
3. Choi-Lundberg, D.L. & Bohn, M.C. (1995) Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat. Brain Res. Dev. Brain Res., 85, 80-88.
4. Déglon, N., Tseng, J.L., Bensadoun, J.C., Zurn, A.D., Arsenijevic, Y., Pereira de Almeida, L., Zufferey, R., Trono, D. & Aebischer, P. (2000) Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. Hum. Gene Ther., 11, 179-190.
5. Georgievska, B., Kirik, D. & Björklund, A. (2002a) Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp. Neurol., 177, 461-474.
6. Georgievska, B., Kirik, D., Rosenblad, C., Lundberg, C. & Björklund, A. (2002b) Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector. Neuroreport, 13, 75-82.
7. Georgievska, B., Kirik, D. & Björklund, A. (2004) Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system. J. Neurosci., 24, 6437-6445.
8. Johansson, M., Friedemann, M., Hoffer, B. & Strömberg, I. (1995) Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic grafts in oculo. Exp. Neurol., 134, 25-34.
9. Kirik, D., Rosenblad, C. & Björklund, A. (1998) Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp. Neurol., 152, 259-277.
10. Kirik, D., Rosenblad, C., Björklund, A. & Mandel, R.J. (2000a) Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system. J. Neurosci., 20, 4686-4700.
11. Kirik, D., Rosenblad, C., Björklund, A. & Mandel, R.J. (2000b) Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: intrastriatal but not intranigral transduction promotes functional regeneration in the Jesioned nigrostriatal system. J. Neurosci., 20, 4686-4700.
12. Kirik, D., Winkler, C. & Björklund, A. (2001) Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration. J. Neurosci., 21, 2889-2896.
13. Kordower, J.H., Emborg, M.E., Bloch, J., Ma, S.Y., Chu, Y., Leventhal, L., McBride, J., Chen, E.Y., Palfi, S., Roitberg, B.Z., Brown, W.O., Holden, J.E., Pyzalski, R., Taylor, M.D., Carvey, P., Ling, Z., Trono, D., Hantraye, P., Déglon, N. & Aebischer, P. (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science, 290, 767-773.
14. Lin, L.F., Doherty, D.H., Lile, J.D., Bektesh, S. & Collins, F. (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science, 260, 1130-1132.
15. Lopez-Martin, E., Caruncho, H.J., Rodriguez-Pallares, J., Guerra, M.J. & Labandeira-García, J.L. (1999) Striatal dopaminergic afferents concentrate in GDNF-positive patches during development and in developing intrastriatal Striatal grafts. J. Comp. Neurol., 406, 199-206.
16. Mehta, V., Hong, M., Spears, J. & Mendez, I. (1998) Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line-derived neurotrophic factor. J. Neurosurg., 88, 1088-1095.
17. Montoya, C.P., Campbell-Hope, L.J., Pemberton, K.D. & Dunnett, S.B. (1991) The 'staircase test': a measure of independent forelimb reaching and grasping abilities in rats. J. Neurosci. Meth., 36, 219-228.
18. Moore, M.W., Klein, R.D., Farinas, I., Sauer, H., Armanini, M., Phillips, H., Reichardt, L.F., Ryan, A.M., Carver-Moore, K. & Rosenthal, A. (1996) Renal and neuronal abnormalities in mice lacking GDNF. Nature, 382, 76-79.
19. Nikkhah, G., Olsson, M., Eberhard, J., Bentlage, C., Cunningham, M.G. & Björklund, A. (1994) A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology. Neuroscience, 63, 57-72.
20. Nirenberg, M.J., Chan, J., Liu, Y., Edwards, R.H. & Pickel, V.M. (1996) Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine. J. Neurosci., 16, 4135-4145.
21. Nirenberg, M.J., Chan, J., Liu, Y., Edwards, R.H. & Pickel, V.M. (1997) Vesicular monoamine transporter-2: immunogold localization in striatal axons and terminals. Synapse, 26, 194-198.
22. Olsson, M., Nikkhah, G., Bentlage, C. & Björklund, A. (1995) Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test. J. Neurosci., 15, 3863-3875.
23. Ostenfeld, T., Tai, Y.T., Martin, P., Deglon, N., Aebischer, P. & Svendsen, C.N. (2002) Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons. J. Neurosci. Res., 69, 955-965.
24. Paxinos, G. & Watson, C. (1998) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.
25. Pichel, J.G., Shen, L., Sheng, H.Z., Granholm, A.C., Drago, J., Grinberg, A., Lee, E.J., Huang, S.P., Saarma, M., Hoffer, B.J., Sariola, H. & Westphal, H. (1996) Defects in enteric innervation and kidney development in mice lacking GDNF. Nature, 382, 73-76.
26. Rosenblad, C., Martinez-Serrano, A. & Björklund, A. (1996) Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience, 75, 979-985.
27. Rosenblad, C., Georgievska, B. & Kirik, D. (2003) Long-term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system. Eur. J. Neurosci., 17, 260-270.
28. Sanchez, M.P., Silos-Santiago, I., Frisen, J., He, B., Lira, S.A. & Barbacid, M. (1996) Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature, 382, 70-73.
29. Sautter, J., Tseng, J.L., Braguglia, D., Aebischer, P., Spenger, C., Seiler, R.W., Widmer, H.R. & Zürn, A.D. (1998) Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts. Exp. Neurol., 149, 230-236.
30. Schallert, T., Kozlowski, D.A., Humm, J.L. & Cocke, R.R. (1997) Use-dependent structural events in recovery of function. Adv. Neurol., 73, 229-238.
31. Sinclair, S.R., Svendsen, C.N., Torres, E.M., Martin, D., Fawcett, J.W. & Dunnett, S.B. (1996) GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts. Neuroreport, 7, 2547-2552.
32. Strömberg, I., Björklund, L., Johansson, M., Tomac, A., Collins, F., Olson, L., Hoffer, B. & Humpel, C. (1993) Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp. Neurol., 124, 401-412.
33. Sullivan, A.M., Pohl, J. & Blunt, S.B. (1998) Growth/differentiation factor 5 and glial cell line-derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson's disease. Eur. J. Neurosci., 10, 3681-3688.
34. West, M.J. (1999) Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci., 22, 51-61.
35. Wilby, M.J., Sinclair, S.R., Muir, E.M., Zietlow, R., Adcock, K.H., Horellou, P., Rogers, J.H., Dunnett, S.B. & Fawcett, J.W. (1999) A glial cell line-derived neurotrophic factor-secreting clone of the Schwann cell line SCTM41 enhances survival and fiber outgrowth from embryonic nigral neurons grafted to the striatum and to the lesioned substantia nigra. J. Neurosci., 19, 2301-2312.
36. Winkler, C., Bentlage, C., Nikkhah, G., Samii, M. & Björklund, A. (1999) Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants. Exp. Neurol., 155, 165-186.
37. Winkler, C., Kirik, D., Björklund, A. & Dunnett, S.B. (2000) Transplantation in the rat model of Parkinson's disease: ectopic versus homotopic graft placement. Prog. Brain Res., 127, 233-265.
38. Yurek, D.M. (1998) Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue. Exp. Neurol., 153, 195-202.